vs

Side-by-side financial comparison of National Healthcare Properties, Inc. (NHPAP) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

National Healthcare Properties, Inc. is the larger business by last-quarter revenue ($84.5M vs $83.1M, roughly 1.0× PROCEPT BioRobotics Corp). National Healthcare Properties, Inc. runs the higher net margin — -27.0% vs -38.1%, a 11.1% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs -3.7%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs -2.2%).

Primary Health Properties plc is a British real estate investment company headquartered in London, England. As of June 2025, the company owns and operates more than 500 primary healthcare facilities within the United Kingdom and Ireland. It is listed on the London Stock Exchange and is also a constituent of the FTSE 250 Index.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

NHPAP vs PRCT — Head-to-Head

Bigger by revenue
NHPAP
NHPAP
1.0× larger
NHPAP
$84.5M
$83.1M
PRCT
Growing faster (revenue YoY)
PRCT
PRCT
+23.9% gap
PRCT
20.2%
-3.7%
NHPAP
Higher net margin
NHPAP
NHPAP
11.1% more per $
NHPAP
-27.0%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
-2.2%
NHPAP

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
NHPAP
NHPAP
PRCT
PRCT
Revenue
$84.5M
$83.1M
Net Profit
$-22.8M
$-31.6M
Gross Margin
36.5%
64.9%
Operating Margin
-7.8%
-4.1%
Net Margin
-27.0%
-38.1%
Revenue YoY
-3.7%
20.2%
Net Profit YoY
-33.9%
-27.9%
EPS (diluted)
$-0.92
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NHPAP
NHPAP
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$84.5M
$76.4M
Q3 25
$86.0M
$83.3M
Q2 25
$85.3M
$79.2M
Q1 25
$86.4M
$69.2M
Q4 24
$87.7M
$68.2M
Q3 24
$88.9M
$58.4M
Q2 24
$88.8M
$53.4M
Net Profit
NHPAP
NHPAP
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$-22.8M
$-29.8M
Q3 25
$-12.5M
$-21.4M
Q2 25
$-20.8M
$-19.6M
Q1 25
$-1.5M
$-24.7M
Q4 24
$-17.0M
$-18.9M
Q3 24
$-40.8M
$-21.0M
Q2 24
$-116.9M
$-25.6M
Gross Margin
NHPAP
NHPAP
PRCT
PRCT
Q1 26
64.9%
Q4 25
36.5%
60.6%
Q3 25
37.4%
64.8%
Q2 25
36.9%
65.4%
Q1 25
33.4%
63.9%
Q4 24
37.4%
64.0%
Q3 24
36.6%
63.2%
Q2 24
38.1%
59.0%
Operating Margin
NHPAP
NHPAP
PRCT
PRCT
Q1 26
-4.1%
Q4 25
-7.8%
-40.6%
Q3 25
2.8%
-27.8%
Q2 25
-6.5%
-28.0%
Q1 25
15.1%
-39.7%
Q4 24
-1.2%
-28.9%
Q3 24
-23.5%
-38.4%
Q2 24
-113.1%
-50.3%
Net Margin
NHPAP
NHPAP
PRCT
PRCT
Q1 26
-38.1%
Q4 25
-27.0%
-39.1%
Q3 25
-14.6%
-25.7%
Q2 25
-24.4%
-24.7%
Q1 25
-1.8%
-35.8%
Q4 24
-19.4%
-27.6%
Q3 24
-45.8%
-35.9%
Q2 24
-131.6%
-48.0%
EPS (diluted)
NHPAP
NHPAP
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$-0.92
$-0.54
Q3 25
$-0.56
$-0.38
Q2 25
$-0.85
$-0.35
Q1 25
$-0.18
$-0.45
Q4 24
$-0.72
$-0.34
Q3 24
$-1.56
$-0.40
Q2 24
$-4.24
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NHPAP
NHPAP
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$57.6M
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$600.1M
$347.7M
Total Assets
$1.7B
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NHPAP
NHPAP
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$57.6M
$286.5M
Q3 25
$47.1M
$294.3M
Q2 25
$47.1M
$302.7M
Q1 25
$71.4M
$316.2M
Q4 24
$21.7M
$333.7M
Q3 24
$32.9M
$196.8M
Q2 24
$29.5M
$214.1M
Total Debt
NHPAP
NHPAP
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
NHPAP
NHPAP
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$600.1M
$365.9M
Q3 25
$627.2M
$380.3M
Q2 25
$647.0M
$385.8M
Q1 25
$674.6M
$389.2M
Q4 24
$684.6M
$402.2M
Q3 24
$702.6M
$241.2M
Q2 24
$756.7M
$251.8M
Total Assets
NHPAP
NHPAP
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$1.7B
$508.1M
Q3 25
$1.7B
$511.5M
Q2 25
$1.8B
$513.1M
Q1 25
$1.8B
$519.4M
Q4 24
$1.9B
$534.0M
Q3 24
$2.0B
$374.1M
Q2 24
$2.1B
$374.4M
Debt / Equity
NHPAP
NHPAP
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NHPAP
NHPAP
PRCT
PRCT
Operating Cash FlowLast quarter
$7.0M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NHPAP
NHPAP
PRCT
PRCT
Q1 26
Q4 25
$7.0M
$-10.3M
Q3 25
$10.2M
$-6.6M
Q2 25
$8.1M
$-15.0M
Q1 25
$-21.2M
$-17.0M
Q4 24
$-79.8M
$-32.4M
Q3 24
$-95.2M
$-18.8M
Q2 24
$6.4M
$-15.7M
Free Cash Flow
NHPAP
NHPAP
PRCT
PRCT
Q1 26
Q4 25
$-12.2M
Q3 25
$-9.5M
Q2 25
$-17.8M
Q1 25
$-18.8M
Q4 24
$-33.6M
Q3 24
$-19.0M
Q2 24
$-16.8M
FCF Margin
NHPAP
NHPAP
PRCT
PRCT
Q1 26
Q4 25
-15.9%
Q3 25
-11.4%
Q2 25
-22.5%
Q1 25
-27.2%
Q4 24
-49.2%
Q3 24
-32.6%
Q2 24
-31.4%
Capex Intensity
NHPAP
NHPAP
PRCT
PRCT
Q1 26
Q4 25
2.4%
Q3 25
3.4%
Q2 25
3.5%
Q1 25
2.7%
Q4 24
1.7%
Q3 24
0.4%
Q2 24
2.0%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NHPAP
NHPAP

Seniors Housing Communities$56.3M67%
Outpatient Medical Facilities$28.1M33%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons